drugset / Trial / NCT02357004
Mechanisms of Refractory Hypertension (Carvedilol)
Withdrawn
University of Alabama at Birmingham
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this protocol is test whether patients with hypertension refractory to antihypertensive treatment have evidence of excessive sympathetic (i.e., nervous system) activity.
Timeline
- Start
- 2015-02
- Primary completion
- 2020-01-31
- Completion
- 2020-01-31
Outcome
Outcome not reported
Stopped: “Change in priority of interventional protocols”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 40 mg | — |
| Subject | Chlorthalidone | Other / unclassified | 12.5 mg | — |